Multigenic resistance to Xylella fastidiosa in wild grapes Vitis sps ... - Nature.com
| 1KJ Stock | EUR 12.61 0.07 0.56% |
Roughly 56% of 10X GENOMICS's investor base is looking to short. The analysis of current outlook of investing in 10X GENOMICS DL suggests that many traders are alarmed regarding 10X GENOMICS's prospects. The current market sentiment, together with 10X GENOMICS's historical and current headlines, can help investors time the market. In addition, many technical investors use 10X GENOMICS DL stock news signals to limit their universe of possible portfolio assets.
10X GENOMICS stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of 10X daily returns and investor perception about the current price of 10X GENOMICS DL as well as its diversification or hedging effects on your existing portfolios.
10X |
Multigenic resistance to Xylella fastidiosa in wild grapes Vitis sps ... Nature.com
Read at news.google.com
 |
10X GENOMICS Fundamental Analysis
We analyze 10X GENOMICS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 10X GENOMICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 10X GENOMICS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
10X GENOMICS is rated below average in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
10X GENOMICS DL Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 10X GENOMICS stock to make a market-neutral strategy. Peer analysis of 10X GENOMICS could also be used in its relative valuation, which is a method of valuing 10X GENOMICS by comparing valuation metrics with similar companies.
Peers
10X GENOMICS Related Equities
| 4LL | Teladoc | 3.92 | ||||
| 9EH | Evolent Health | 3.88 | ||||
| 2HE | Healthequity | 1.69 | ||||
| COPA | COMPUGROUP MEDSPADR | 0.97 | ||||
| 1KJ | 10X GENOMICS | 0.56 | ||||
| COP | CompuGroup Medical | 0.28 | ||||
| 3CM | RLX TECH | 0.54 | ||||
| COP | Compugroup Medical | 0.64 | ||||
| VEE | Veeva Systems | 2.16 | ||||
| 1XZ | Ping An | 2.60 |
Complementary Tools for 10X Stock analysis
When running 10X GENOMICS's price analysis, check to measure 10X GENOMICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X GENOMICS is operating at the current time. Most of 10X GENOMICS's value examination focuses on studying past and present price action to predict the probability of 10X GENOMICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X GENOMICS's price. Additionally, you may evaluate how the addition of 10X GENOMICS to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |